StonvexLoading…
StonvexStonvexStonvexCore line items from PAMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $598.06M | $714.65M | $810.81M | $946.86M |
Operating Income | $-64.06M | $-36.77M | $30.31M | $123.77M |
Net Income | $-52.61M | $-31.80M | $18.42M | $90.67M |
EPS (Diluted) | $-2.48 | $-1.45 | $0.83 | $4.04 |
Total Assets | $697.91M | $741.65M | $760.46M | $749.16M |
Total Liabilities | $487.43M | $464.15M | $446.24M | $448.98M |
Cash & Equivalents | $35.23M | $68.06M | $100.61M | $74.09M |
Free Cash Flow OCF − CapEx | $-23.41M | $-81.72M | $80.52M | $104.85M |
Shares Outstanding | 20.93M | 21.78M | 22.02M | 22.17M |